News about Global Pharma

Fapon Biopharma Receives FDA Approval of IND for FP008 for Solid Tumors

FP008 is a novel anti-PD-1×IL-10M fusion protein with a unique mechanism of action (MOA) and therapeutic potential for anti-PD-1 naïve or resistant patients.

Global Pharma | 03/03/2025 | By Aishwarya

Arrowhead Pharmaceuticals Expands its New Patient-Centric Resources for FCS Patients

This new phase introduces a dedicated educational website, and the Spotlight on FCS white paper, which provides essential resources and support for those affected by Familial Chylomicronemia Syndrome (FCS).

Global Pharma | 03/03/2025 | By Aishwarya

Magnet Biomedicine and Lilly to Develop Novel Molecular Glue Medicines

The collaboration will leverage Magnet's TrueGlue™ discovery platform to identify molecular glues capable of inducing protein proximity and cooperativity, enabling novel mechanisms of action to address difficult-to-drug targets spanning multiple diseases with unmet medical need.

Global Pharma | 01/03/2025 | By Aishwarya

Foresight Diagnostics Expands Strategic Partnership with Allogene Therapeutics

Under the strategic collaboration, Allogene and Foresight will work together to support the development of Foresight Diagnostics' MRD assay in the EU, UK, Canada and Australia in support of Allogene's clinical development of cema-cel.

Global Pharma | 01/03/2025 | By Manvi

Nxera Pharma and Holling to Commercialize Daridorexant in Taiwan

Daridorexant is an oral dual orexin receptor antagonist (DORA) for the treatment of insomnia that selectively binds to receptors of the wake-promoting neuropeptide orexin (OX1R and OX2R), inhibiting excessive wakefulness and facilitating the transition to sleep.

Global Pharma | 01/03/2025 | By Aishwarya

ProRx Pharma Expands Production to Meet Demand for Drugs on FDA Shortage List

ProRx is currently expanding its operations to a total of 6,888 square feet, doubling its existing 3,400-square-foot pharmaceutical and manufacturing facility.

Global Pharma | 01/03/2025 | By Aishwarya

USFDA Approves Fapon Biopharma's Investigational New Drug (IND) Application for FP008

Fapon Biopharma announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for FP008, its first-in-class immunocytokine designed to address the unmet need in patients with solid tumors refractory to anti-PD-1 therapy.

Global Pharma | 28/02/2025 | By Manvi

Senores Pharmaceuticals Commence Operations at Greenfield API Facility at Mehsana, Gujarat

Senores Pharmaceuticals Ltd. has inaugurated and commenced manufacturing activities at its greenfield API manufacturing facility in Mehsana. This is Senores’ second API manufacturing facility and has an installed capacity of ~100 Metric Tons per Annum.

Global Pharma | 28/02/2025 | By Manvi

Systech Develops UniSecure artAI for Life Sciences and Pharmaceutical Industries

artAI uses advanced machine vision and machine learning to create a digital blueprint of key packaging artwork features, enabling precise verification and quality inspection through pattern recognition.

Global Pharma | 28/02/2025 | By Aishwarya

Zydus Lifesciences to Launch Protection Against New Strain of Influenza Virus

The Quadrivalent Inactivated Influenza vaccine has been developed at the Vaccine Technology Centre (VTC) in Ahmedabad which has proven capabilities in researching, developing, and manufacturing of safe and efficacious vaccines.

Global Pharma | 28/02/2025 | By Aishwarya